Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 6,785 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 6,785 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $3.97, for a total value of $26,936.45. Following the completion of the transaction, the chief executive officer owned 132,065 shares in the company, valued at $524,298.05. This represents a 4.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Amit Gupta also recently made the following trade(s):

• On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The shares were sold at an average price of $4.03, for a total value of $26,904.28.
• On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $42,319.60.
• On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $28,526.22.

Cardlytics Trading Up 1.7%

Shares of NASDAQ:CDLX opened at $4.12 on Wednesday. The stock’s fifty day simple moving average is $4.36 and its two-hundred day simple moving average is $6.99. Cardlytics, Inc. has a 1-year low of $3.49 and a 1-year high of $32.80. The stock has a market cap of $23.94 million, a PE ratio of -0.22 and a beta of 0.62.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($1.50) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.80. The firm had revenue of $36.88 million for the quarter, compared to the consensus estimate of $37.00 million. Cardlytics had a negative net margin of 55.92% and a negative return on equity of 956.56%. On average, sell-side analysts forecast that Cardlytics, Inc. will post -3.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CDLX has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Wall Street Zen raised shares of Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, August 8th. Lake Street Capital set a $10.00 target price on Cardlytics in a research note on Friday, May 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. One research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Cardlytics currently has a consensus rating of “Sell” and an average price target of $10.00.

Institutional Trading of Cardlytics

Several hedge funds have recently added to or reduced their stakes in CDLX. Bank of America Corp DE boosted its stake in Cardlytics by 262.7% in the third quarter. Bank of America Corp DE now owns 1,632,786 shares of the company’s stock valued at $3,968,000 after acquiring an additional 1,182,593 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Cardlytics by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after acquiring an additional 20,908 shares during the period. UBS Group AG increased its stake in shares of Cardlytics by 112.5% during the 3rd quarter. UBS Group AG now owns 458,066 shares of the company’s stock worth $1,113,000 after purchasing an additional 242,536 shares during the last quarter. Invesco Ltd. increased its stake in shares of Cardlytics by 38.1% during the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock worth $196,000 after purchasing an additional 46,973 shares during the last quarter. Finally, Jane Street Group LLC raised its holdings in shares of Cardlytics by 263.0% in the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock worth $267,000 after purchasing an additional 117,687 shares during the period. Institutional investors own 68.10% of the company’s stock.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.